This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Dr. Falk Pharma Gmbh. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Tanju Nacak in Pharmaceutical Formulations
Introduction
Tanju Nacak is a notable inventor based in Gottenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations aimed at treating inflammatory diseases of the colon. With a total of two patents to his name, Nacak's work reflects a commitment to enhancing medicinal safety and efficacy.
Latest Patents
Nacak's latest patents include a groundbreaking formulation titled "Pellets having a multi-layer structure for delayed release of the active substance in the distal colon." This invention discloses a pharmaceutical formulation that consists of a capsule containing pellets designed for oral administration. The formulation delivers the active substance in a targeted manner to the colon, achieving maximum release at the site of action while maintaining low blood plasma levels. The results from pharmaceutical tests, including in vitro release and clinical studies, support the formulation's efficacy and safety.
Another significant patent is the "Optimized high-dose mesalazine-containing tablet." This invention relates to an oral enteric high-dose tablet that comprises mesalazine as the active substance. The optimized formulation aims to improve the treatment outcomes for patients suffering from inflammatory bowel diseases.
Career Highlights
Tanju Nacak is associated with Dr. Falk Pharma GmbH, a company known for its focus on innovative pharmaceutical solutions. His work at the company has been instrumental in advancing therapeutic options for patients with gastrointestinal disorders.
Collaborations
Nacak has collaborated with notable colleagues, including Roland Greinwald and Rudolf Wilhelm. These partnerships have contributed to the successful development of his patented formulations.
Conclusion
Tanju Nacak's contributions to pharmaceutical innovations demonstrate his dedication to improving treatment options for inflammatory diseases of the colon. His patents reflect a blend of scientific rigor and practical application, underscoring the importance of targeted drug delivery systems in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile